Speaker

Dr Molly Li is a thoracic medical oncologist who works as clinical assistant professor in the Chinese University of Hong Kong. His research interests in lung cancer include screening, translational and biomarker research, as well as drug development. He is the site principal investigator of multiple sponsor-initiated and investigator-initiated drug trials and screening study. He serves at the international advisory board for Lancet Respiratory Medicine and as reviewer for other journals such as Journal of Thoracic Oncology, Cancer Treatment Reviews, Cell Reports Medicine, etc. Dr Li is a member of ASCO/ESMO/IASLC (International Association for Study of Lung Cancer)/ATORG (Asian Thoracic Oncology Research Group)/CTONG (Chinese Thoracic Oncology Group). He is also an invited speaker in multiple local and regional conferences and educational courses.